Continued treatment with Briumvi provided sustained clinical benefits to patients with relapsing MS, particularly when ...

Epstein–Barr virus infects most adults. Understanding its role in Multiple Sclerosis could transform prevention and treatment ...

Roche has shared the numbers behind its phase 3 win in primary progressive multiple sclerosis (PPMS), linking its BTK ...

A new study reveals how Epstein-Barr virus may provoke immune cells to attack the brain, offering fresh hope for treating multiple sclerosis.

New research suggests that multiple sclerosis may begin influencing patients’ health far earlier than previously recognized.

Some MS diets may help lower inflammation marker levels, but evidence from clinical trials remains limited, according to a new review paper.

Nektar Therapeutics (Nasdaq: NKTR) today announced an academic research collaboration with the University of California, San ...

New research shows early Multiple Sclerosis brain damage is dynamic and reversible. Myelin swellings can shrink and disappear ...

Multiple sclerosis is a central nervous system autoimmune condition that damages myelin sheath that protects the nervous system, affects brain and spinal cord and leads to aggravated conditions like ...

NESS ZIONA, Israel, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company focused on introducing innovative long-acting ...

Discover how to plan for travel with multiple sclerosis. Get tips on managing fatigue, mobility, heat sensitivity, choosing destinations, and what to bring for ease.